143 related articles for article (PubMed ID: 27931059)
21. The launch of Respiratory Investigation and its scope.
Nukiwa T
Respir Investig; 2012 Mar; 50(1):1-2. PubMed ID: 22554853
[No Abstract] [Full Text] [Related]
22. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
Greillier L; Barlesi F
Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
[No Abstract] [Full Text] [Related]
23. Spectacular Progress in Lung Cancer Care.
Oncology (Williston Park); 2021 Jan; 35(1):26-28. PubMed ID: 33443768
[TBL] [Abstract][Full Text] [Related]
24. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?
Einhorn LH
J Clin Oncol; 2008 Jul; 26(21):3485-6. PubMed ID: 18506022
[No Abstract] [Full Text] [Related]
25. [Erlotinib. A new option for non-small cell lung cancer].
Polk B
Med Monatsschr Pharm; 2006 Jan; 29(1):4-6. PubMed ID: 16463547
[No Abstract] [Full Text] [Related]
26. New platinum derivatives in advanced non-small cell lung cancer.
Crinò L; Cappuzzo F
Suppl Tumori; 2002; 1(4):S24-5. PubMed ID: 12415810
[No Abstract] [Full Text] [Related]
27. Non-small cell lung cancer: from targeted therapy to tailored therapy.
Malgieri S; Feliciano S; Bosso D; Federico P; Palmieri G; De Placido S; Di Lorenzo G; Buonerba C
Expert Opin Pharmacother; 2012 Sep; 13(13):1817-9. PubMed ID: 22803703
[No Abstract] [Full Text] [Related]
28. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
Sculier JP; Meert AP
J Thorac Oncol; 2008 Mar; 3(3):320; author reply 320-2. PubMed ID: 18317082
[No Abstract] [Full Text] [Related]
29. [Established new drugs in the chemotherapy of non-small-cell lung carcinoma (NSCLC)].
Serke M
Dtsch Med Wochenschr; 2000 Feb; 125(8):225. PubMed ID: 10723459
[No Abstract] [Full Text] [Related]
30. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
Gridelli C
Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
[No Abstract] [Full Text] [Related]
31. More questions about neoadjuvant chemotherapy in lung cancer.
Vallières E
Oncology (Williston Park); 2009 Sep; 23(10):892, 896. PubMed ID: 19839431
[No Abstract] [Full Text] [Related]
32. [Personalized, targeted treatment of non-small cell lung cancer].
Wolf J
Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
[No Abstract] [Full Text] [Related]
33. The evolving role of histology in the treatment of non-small cell lung cancer.
Rana N; Khurshid H
Med Health R I; 2010 Oct; 93(10):317-9. PubMed ID: 21284271
[No Abstract] [Full Text] [Related]
34. Clinical trial of Iressa.
FDA Consum; 2005; 39(2):4. PubMed ID: 16121415
[No Abstract] [Full Text] [Related]
35. [Gefitinib in non-small cell lung cancer].
Nakagawa K
Nihon Rinsho; 2004 Jul; 62(7):1312-20. PubMed ID: 15283149
[No Abstract] [Full Text] [Related]
36. New chemotherapeutic agents in non-small-cell lung cancer.
Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
[No Abstract] [Full Text] [Related]
37. [Adjuvant therapy in non-small-cell lung cancer. For].
Santomaggio C
Suppl Tumori; 2004; 3(4):S48-9. PubMed ID: 15206211
[No Abstract] [Full Text] [Related]
38. Targeting vascular endothelial growth factor in lung cancer.
Hasani A; Leighl NB
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S484-6. PubMed ID: 21102250
[No Abstract] [Full Text] [Related]
39. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?
Kalemkerian G
J Clin Oncol; 2005 Feb; 23(6):1325-6; author reply 1326-7. PubMed ID: 15718337
[No Abstract] [Full Text] [Related]
40. [The role of adjuvant chemotherapy in non-small-cell lung cancer. Against].
Lippe P; Mattioli R
Suppl Tumori; 2004; 3(4):S45-7. PubMed ID: 15206210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
